Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jiaguo Huang, Hongxiang Ding, Chao Feng, Dikai Mao & Shengcheng Tai. (2024) Spontaneous Prostatic Hemorrhage in a COVID-19 Patient: A Case Report. Infection and Drug Resistance 16, pages 3035-3040.
Read now
Read now
Yongtai Cho, Sungho Bea, Ji-Hwan Bae, Dong Hyun Kim, Jong Hee Lee & Ju-Young Shin. (2023) Cognitive dysfunction following finasteride use: a disproportionality analysis of the global pharmacovigilance database. Expert Opinion on Drug Safety 0:0, pages 1-7.
Read now
Read now
Ja Hyeon Ku, Jung Ki Shin, Min Chul Cho, Jae Kyung Myung, Kyung Chul Moon & Jae-Seung Paick. (2009) Effect of dutasteride on the expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and microvessel density in rat and human prostate tissue. Scandinavian Journal of Urology and Nephrology 43:6, pages 445-453.
Read now
Read now
Altug Tuncel, Kemal Ener, Ozge Han, Varol Nalcacioglu, Omur Aydin, Selda Seckin & Ali Atan. (2009) Effects of short-term dutasteride and Serenoa repens on perioperative bleeding and microvessel density in patients undergoing transurethral resection of the prostate. Scandinavian Journal of Urology and Nephrology 43:5, pages 377-382.
Read now
Read now
Robert G. Hahn, Li Yin, Jan Ekengren & Lars Sandfeldt. (2006) Vascular endothelial growth factor in serum indicates cardiovascular risk in urology patients. Scandinavian Journal of Urology and Nephrology 40:2, pages 144-148.
Read now
Read now
Articles from other publishers (31)
Gorrepati Rohith, Manoj K. Das, Parnandi Bhaskar Rao, Abhay Singh Gaur, Swarnendu Mandal, Mathan Kumar Ramasubbu, Kirti Singh, Sambit Tripathy & Prasant Nayak. (2024) Efficacy of Low Dose Intravenous Epinephrine Infusion in Improving Perioperative Outcomes in Patients Undergoing Transurethral Resection of Prostate: A Prospective Parallel Arm Double-Blind Randomized Control Trial. Urology 184, pages 169-175.
Crossref
Crossref
Thomas Hughes, Philip Harper & Bhaskar K. Somani. (2023) Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques. Life 13:10, pages 2077.
Crossref
Crossref
UE Oyibo, CV Nwagu, IN Osakpamwan & J Aku. (2023) Intractable haematuria due to giant prostatic hyperplasia in a resource-challenged centre: between the devil and the deep blue sea. African Urology 3:3, pages 131-133.
Crossref
Crossref
Sachin Malde, Wayne Lam, Zainal Adwin & Hashim Hashim. (2021) Pharmacological and interventional treatment of benign prostatic obstruction: An evidence‐based comparative review. BJUI Compass 2:4, pages 238-259.
Crossref
Crossref
C.B. Lima, D.S.R. Angrimani, R.B. Flores & C.I. Vannucchi. (2021) Endocrine, prostatic vascular, and proapoptotic changes in dogs with benign prostatic hyperplasia treated medically or surgically. Domestic Animal Endocrinology 75, pages 106601.
Crossref
Crossref
Nitesh Kumar, SunilK Palve, Karthik Marripeddi & Sanath Thantla. (2021) Effect of short-term preoperative dutasteride and finasteride on bleeding after transurethral resection of the prostate: A prospective randomized study. Urological Science 32:3, pages 125.
Crossref
Crossref
Marcello Henrique Araújo da Silva, João Henrique Duque Estrada, Bianca Martins Gregório, Francisco José Barcellos Sampaio & Diogo Benchimol de Souza. (2021) Does treatment with dutasteride or finasteride has impact on renal morphology? Experimental study. Acta Cirúrgica Brasileira 36:7.
Crossref
Crossref
Eriawan Agung Nugroho, Selly Adyta Kemara, Siti Amarwati & Tommy Supit. (2019) The Effect of Dutasteride and Tomato Extract Combination on Reducing Blood Loss after Transurethral Resection of the Prostate. Urological Science 30:5, pages 216-219.
Crossref
Crossref
Jaime A. Cavallo & Steven A. Kaplan. 2018. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
189
206
.
Matthew Bruha & Charles Welliver. (2017) Is There a Role for Preoperative 5 Alpha Reductase Inhibitors in Reducing Prostate Vascularity and Blood Loss?. Current Urology Reports 18:10.
Crossref
Crossref
Cheuk Fan Shum, Weida Lau & Chang Peng Colin Teo. (2017) Medical therapy for clinical benign prostatic hyperplasia: α1 Antagonists, 5α reductase inhibitors and their combination. Asian Journal of Urology 4:3, pages 185-190.
Crossref
Crossref
Yi-Ping Zhu, Bo Dai, Hai-Liang Zhang, Guo-hai Shi & Ding-Wei Ye. (2015) Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. BMC Urology 15:1.
Crossref
Crossref
Marcelo Langer Wroclawski, Ariê Carneiro, Rodrigo Alves Tristão, Paulo Kouiti Sakuramoto, Jorg Daoud Merched Youssef, Antonio Correa Lopes Neto, Lucila Heloísa Simardi Santiago & Antonio Carlos Lima Pompeo. (2015) Giant prostatic hyperplasia: report of a previously asymptomatic man presenting with gross hematuria and hypovolemic shock. Einstein (São Paulo) 13:3, pages 420-422.
Crossref
Crossref
He-lin Tian, Chao-xian Zhao, Hai-ying Wu, Zhong-xin Xu, Li-shun Wei, Ru-tong Zhao & Dong-ling Jin. (2015) Finasteride Reduces Microvessel Density and Expression of Vascular Endothelial Growth Factor in Renal Tissue of Diabetic Rats. The American Journal of the Medical Sciences 349:6, pages 516-520.
Crossref
Crossref
Robert J. Carrasquillo, Sean W. Nealy & David S. Wang. (2014) 5-Alpha-reductase inhibitors in diseases of the prostate. Current Opinion in Endocrinology, Diabetes & Obesity 21:6, pages 488-492.
Crossref
Crossref
Fabio Montico, Larissa Akemi Kido, Amanda Cia Hetzl, Raísa Mistieri Lorencini, Eduardo Marcelo Cândido & Valéria Helena Alves Cagnon. (2014) Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice. Histochemistry and Cell Biology 142:3, pages 269-284.
Crossref
Crossref
O. M. Aboumarzouk, M. Z. Aslam, A. Wedderburn, K. Turner, O. Hughes & H. G. Kynaston. (2013) Should Finasteride Be Routinely Given Preoperatively for TURP?. ISRN Urology 2013, pages 1-7.
Crossref
Crossref
Huan-Tao Zong, Xiao-Xia Peng, Chen-Chen Yang & Yong Zhang. (2011) A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia. Asian Journal of Andrology 13:6, pages 812-818.
Crossref
Crossref
Kevin T. McVary, Claus G. Roehrborn, Andrew L. Avins, Michael J. Barry, Reginald C. Bruskewitz, Robert F. Donnell, Harris E. Foster, Chris M. Gonzalez, Steven A. Kaplan, David F. Penson, James C. Ulchaker & John T. Wei. (2011) Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia. Journal of Urology 185:5, pages 1793-1803.
Crossref
Crossref
Ettore De Berardinis, Gabriele Antonini, Gian Maria Busetto, Vincenzo Gentile, Franco Di Silverio & Antonella Rossi. (2008) Reduced intraoperative bleeding during transurethral resection of the prostate: Evaluation of finasteride, vascular endothelial growth factor, and CD34. Current Prostate Reports 6:3, pages 123-127.
Crossref
Crossref
Ardeshir R Rastinehad, Michael C Ost, Brian A VanderBrink, David N Siegel & Louis R Kavoussi. (2008) Persistent prostatic hematuria. Nature Clinical Practice Urology 5:3, pages 159-165.
Crossref
Crossref
Ardeshir R. Rastinehad, Drew M. Caplin, Michael C. Ost, Brian A. VanderBrink, Igor Lobko, Gopal H. Badlani, Gary H. Weiss, Louis R. Kavoussi & David N. Siegel. (2008) Selective Arterial Prostatic Embolization (SAPE) for Refractory Hematuria of Prostatic Origin. Urology 71:2, pages 181-184.
Crossref
Crossref
Robert G. Hahn, Tim Fagerström, Teuvo L.J. Tammela, Oncko Van Vierssen Trip, Hans Olav Beisland, Annette Duggan & Betsy Morrill. (2007) Blood loss and postoperative complications associated with transurethral resection of the prostate after pretreatment with dutasteride. BJU International 99:3, pages 587-594.
Crossref
Crossref
Corinne Cayatte, Catherine Pons, Jean-Marie Guigonis, Jérôme Pizzol, Laetitia Elies, Philippe Kennel, David Rouquié, Rémi Bars, Bernard Rossi & Michel Samson. (2006) Protein Profiling of Rat Ventral Prostate following Chronic Finasteride Administration. Molecular & Cellular Proteomics 5:11, pages 2031-2043.
Crossref
Crossref
Alexandros G. Lekas, Andreas C. Lazaris, Michael Chrisofos, Athanasios G. Papatsoris, Dimitrios Lappas, Efstratios Patsouris & Charalampos Deliveliotis. (2006) Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia. Urology 68:2, pages 436-441.
Crossref
Crossref
A. Erdem Canda, M. Ugur Mungan, Osman Yilmaz, Kutsal Yorukoglu, Emre Tuzel & Ziya Kirkali. (2006) Effects of finasteride on the vascular surface density, number of microvessels and vascular endothelial growth factor expression of the rat prostate. International Urology and Nephrology 38:2, pages 275-280.
Crossref
Crossref
John F. Donohue, Dickon Hayne, Uttara Karnik, David R. Thomas & Michael C. Foster. (2005) Randomized, placebo‐controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks. BJU International 96:9, pages 1319-1322.
Crossref
Crossref
Guven Aslan, Sertac Cimen, Kutsal Yorukoglu, Burcin Tuna, Devrim Sonmez, Ugur Mungan & Ilhan Celebi. (2005) Vascular endothelial growth factor expression in untreated and androgen-deprived patients with prostate cancer. Pathology - Research and Practice 201:8-9, pages 593-598.
Crossref
Crossref
Joshua M Stern, Jie Chen, Sara B Peters, Peter J Stahl, Maher El-Chaar, Diane Felsen & Dix P Poppas. (2004) Testosterone treatment of human foreskin in a novel transplant model. Urology 63:5, pages 999-1003.
Crossref
Crossref
Maureen E. Harper, Lindy Goddard, Christopher Smith & Robert I. Nicholson. (2003) Characterization of a transplantable hormone‐responsive human prostatic cancer xenograft TEN12 and its androgen‐resistant sublines. The Prostate 58:1, pages 13-22.
Crossref
Crossref
H. Christoph Klingler. (2003) New innovative therapies for benign prostatic hyperplasia: any advance?. Current Opinion in Urology 13:1, pages 11-15.
Crossref
Crossref